United Therapeutics (UTHR) Approves $100M Buyback
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Join SI Premium – FREE
United Therapeutics Corporation (Nasdaq: UTHR) approves a new $100 million share repurchase program.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- United Therapeutics completes enrollment in PPF lung fibrosis trial
- Almonty Industries launches $300M share repurchase program
- Cycurion board approves $500,000 share repurchase program
Create E-mail Alert Related Categories
Stock BuybacksRelated Entities
Stock BuybackSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
